PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29290940-15 2017 LPC-induced apoptosis, and IL-8 expression/secretion was attenuated by LY294002, a PI3K/Akt inhibitor. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 71-79 C-X-C motif chemokine ligand 8 Homo sapiens 27-31 32112175-9 2020 In vitro, the PI3K inhibitors (BZE235 and LY294002) ameliorated GC insensitivity in H2O2/TNFalpha-induced IL-8 release from U937 cells by independently restoring the activity of HDAC2 or inhibiting the activation of transcription factors. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 42-50 C-X-C motif chemokine ligand 8 Homo sapiens 106-110 31684995-10 2019 When we stimulated HCC cells with exogenous IL-8, cell invasion and the levels of integrin beta3, p-PI3K, and p-Akt increased, which could be effectively reversed by adding PI3K inhibitor LY294002. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 188-196 C-X-C motif chemokine ligand 8 Homo sapiens 44-48 29402343-10 2018 The increased phosphorylations of PI3K, AKT, and mTOR, and the upregulation of CXCL8 induced by miR-204 suppression were all abolished by the addition of LY294002 and AZD8055 (inhibitors of PI3K/AKT and mTOR, respectively). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 154-162 C-X-C motif chemokine ligand 8 Homo sapiens 79-84 34227646-6 2021 Subsequently, it was demonstrated treatment with PI3K/AKT pathway inhibitor (LY294002) or Wnt/beta-catenin pathway inhibitor (Dickkopf-1, DKK-1) could further enhance the anti-inflammatory and antioxidant effects of RSV by downregulating the expression of IL-1beta, IL-6, IL-8 and TNFalpha, and the production of MDA, and increasing the activity of SOD and GSH-Px in LPS-induced HGFs. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 77-85 C-X-C motif chemokine ligand 8 Homo sapiens 272-276 33505496-9 2021 Both hypoxia and IL-8 may promote angiogenesis which was suppressed by JR. Western blot showed that IL-8 upregulated the expression of phosphorylation of AKT, ERK, NF-kappaB, and VEGFR, which were inhibited by JR. On the other hand, effects of IL-8 on the increase of p-AKT and p-ERK were also blocked by LY294002 and U0126, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 305-313 C-X-C motif chemokine ligand 8 Homo sapiens 17-21 33505496-9 2021 Both hypoxia and IL-8 may promote angiogenesis which was suppressed by JR. Western blot showed that IL-8 upregulated the expression of phosphorylation of AKT, ERK, NF-kappaB, and VEGFR, which were inhibited by JR. On the other hand, effects of IL-8 on the increase of p-AKT and p-ERK were also blocked by LY294002 and U0126, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 305-313 C-X-C motif chemokine ligand 8 Homo sapiens 100-104 33505496-9 2021 Both hypoxia and IL-8 may promote angiogenesis which was suppressed by JR. Western blot showed that IL-8 upregulated the expression of phosphorylation of AKT, ERK, NF-kappaB, and VEGFR, which were inhibited by JR. On the other hand, effects of IL-8 on the increase of p-AKT and p-ERK were also blocked by LY294002 and U0126, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 305-313 C-X-C motif chemokine ligand 8 Homo sapiens 100-104 31636329-8 2019 The reduced corticosteroid responsiveness may be mediated by glycolytic reprogramming, specifically glycolysis-associated PI3K signaling, as PI3K inhibitor LY294002 restored the sensitivity of CXCL8 secretion to corticosteroids in A549 Rho-0 cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 156-164 C-X-C motif chemokine ligand 8 Homo sapiens 193-198 29908644-12 2018 Concomitantly, LY294002 inhibited CdCl2-induced IL-8 in JEG-3 cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 15-23 C-X-C motif chemokine ligand 8 Homo sapiens 48-52 29175450-6 2018 HCh-3 and LY294002 (alone or in combination) as well as Tiotropium (Spiriva ) or Olodaterol (alone or in combination) all reduced the levels of pPEBP1, pbeta2AR, pERK1/2, ROS, NOX-4, and IL-8 in 16HBE LECSE compared to untreated cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 10-18 C-X-C motif chemokine ligand 8 Homo sapiens 187-191 27588140-6 2016 Furthermore, IL-8 could induce AKT phosphorylation, and the phosphatidylinositol-4,5-bisphosphate 3-kinase inhibitor LY294002 could inhibit the EMT of RCC cells that was induced by IL-8. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 117-125 C-X-C motif chemokine ligand 8 Homo sapiens 181-185 28371277-7 2017 The miR-138 mimic and LY294002 groups showed decreased concentrations of TNF-alpha, IL-6, IL-8 and NO and reduced activities of LDH and eNOS, while opposite trends were observed in the miR-138 inhibitor group. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 22-30 C-X-C motif chemokine ligand 8 Homo sapiens 90-94 27740938-10 2016 LY294002 attenuated the 7-KC-induced apoptosis and IL-8 mRNA expression of endothelial cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 51-55 25058399-10 2014 LY294002, a PI3K inhibitor, inhibited HPV-16 oncoprotein-induced activation of Akt, P70S6K, and P85S6K, expression of HIF-1alpha, VEGF, and IL-8, and in vitro angiogenesis. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 140-144 26121010-5 2015 The effect of leptin on IL-8 could visibly abolished by the inhibitor of PI3K LY294002. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 78-86 C-X-C motif chemokine ligand 8 Homo sapiens 24-28 25748730-6 2015 Combining paeoniflorin with U0126 or LY294002 at low doses showed supra-additive inhibition of not only phospho-ERK1/2 and phospho-Akt by 46.4% and 35.0%, but also IL-8 release by 42.4% and 36.1% and IL-8 mRNA expression by 43.5% and 31.8%, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 37-45 C-X-C motif chemokine ligand 8 Homo sapiens 164-168 25748730-6 2015 Combining paeoniflorin with U0126 or LY294002 at low doses showed supra-additive inhibition of not only phospho-ERK1/2 and phospho-Akt by 46.4% and 35.0%, but also IL-8 release by 42.4% and 36.1% and IL-8 mRNA expression by 43.5% and 31.8%, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 37-45 C-X-C motif chemokine ligand 8 Homo sapiens 200-204 24669186-10 2014 The production of IL-1beta, IL-6, and IL-8 induced by TNF-alpha was decreased by the phosphatidylinositol-3 kinase inhibitor LY294002, suggesting that inhibition of Akt activation might inhibit IL-1beta, IL-6, and IL-8 production induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 125-133 C-X-C motif chemokine ligand 8 Homo sapiens 38-42 24669186-10 2014 The production of IL-1beta, IL-6, and IL-8 induced by TNF-alpha was decreased by the phosphatidylinositol-3 kinase inhibitor LY294002, suggesting that inhibition of Akt activation might inhibit IL-1beta, IL-6, and IL-8 production induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 125-133 C-X-C motif chemokine ligand 8 Homo sapiens 214-218 23403077-8 2013 The growth of the tumor spheres could also be reduced by the CXCR2 specific inhibitor SB225002 or the PI3K/AKT inhibitor LY294002, indicating that the endogenously produced CXCL8 plays an autocrine role in the growth of the tumor spheres. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 121-129 C-X-C motif chemokine ligand 8 Homo sapiens 173-178 21545687-5 2012 Tumour necrosis factor-alpha (TNF-alpha) significantly induced phosphorylation of p38 MAPK, ERK, Akt and production of IL-8 from HCC cells, which were prevented by SB203580 (p38 MAPK inhibitor), PD98059 (ERK inhibitor), LY294002 and Wortmannin (PI3K inhibitor) and SB328437 (CCR3 inhibitor). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 220-228 C-X-C motif chemokine ligand 8 Homo sapiens 119-123 22610073-11 2012 Further, IL-8-promoted migration and invasion could be abolished by either the application of the phosphoinositide-3-kinase inhibitor LY294002 or the knock down of AKT expression by using small-interfering RNA. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 134-142 C-X-C motif chemokine ligand 8 Homo sapiens 9-13 22420994-10 2012 Also, LY294002, an inhibitor of the Akt/PI3K pathway, abrogated the MA-mediated induction of IL-6 and IL-8 by 77.9 +- 6.6% and 81.4 +- 2.6%, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 6-14 C-X-C motif chemokine ligand 8 Homo sapiens 102-106 20050188-10 2009 BK-induced IL-8 release was attenuated by inhibitors of phospholipase C (U73122), p38 (SB203580), JNK (SP600125), ERK 1/2 (PD98059) MAPKs, phosphoinositide 3-kinase (LY294002), NF-kappaB (BAY-117085) and by the glucocorticoid dexamethasone. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 166-174 C-X-C motif chemokine ligand 8 Homo sapiens 11-15 20451499-4 2010 Thrombin activated Akt, PKC and MAPK in HAoSMC, and thrombin-mediated expression of IL-6 and CXCL8 was significantly inhibited by LY294002, AKT IV, RO318220, and GF109203X as well as by diphenyleneiodium at the messenger RNA and the protein levels. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 130-138 C-X-C motif chemokine ligand 8 Homo sapiens 93-98 21468084-7 2011 Further, the over-expression of LPS-induced IL-8 mRNA in HUVECs was suppressed by a p38 MAPK inhibitor (SB203580, 25 mumol/L) or a phosphatidylinositol 3-kinase (PI3K) inhibitor (LY294002, 50 mumol/L). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 179-187 C-X-C motif chemokine ligand 8 Homo sapiens 44-48 21266580-3 2011 Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 108-116 C-X-C motif chemokine ligand 8 Homo sapiens 17-21 21266580-3 2011 Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 108-116 C-X-C motif chemokine ligand 8 Homo sapiens 22-27 21266580-3 2011 Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 108-116 C-X-C motif chemokine ligand 8 Homo sapiens 40-44 21266580-3 2011 Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by a PI3K inhibitor (LY294002), an Akt inhibitor (1-L-6-hydroxymethyl-chiro-inositol-2-((R)-2-O-methyl-3-O-octadecylcarbonate)), and the dominant negative mutants of Rac1 (RacN17) and Akt (AktDN). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 108-116 C-X-C motif chemokine ligand 8 Homo sapiens 45-50 21215400-10 2011 The AcLDL-induced IL-8 production was inhibited by LY294002 and filipin. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 51-59 C-X-C motif chemokine ligand 8 Homo sapiens 18-22 17130184-9 2007 The inhibitors of PI-3K wortmannin and LY294002 inhibited the chemotaxis and suppressed IL-8-evoked dephosphorylation and rephosphorylation of cofilin. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 39-47 C-X-C motif chemokine ligand 8 Homo sapiens 88-92 17786963-5 2008 The HNP-induced IL-8 production was blocked by the Src tyrosine kinase inhibitor PP2, MEK1/2 inhibitor U0126, and the phosphatidylinositol 3 kinase (PI3K) inhibitor LY294002, but not by the JNK inhibitor SP600125 in both cell types. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 165-173 C-X-C motif chemokine ligand 8 Homo sapiens 16-20 17606477-6 2007 LY294002 and rapamycin each abrogated the IL-8-promoted phosphorylation of rS6 and attenuated the rate of AIPC cell proliferation. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 42-46 17314215-11 2007 TNF-alpha-induced production of IL-1beta, IL-6 and IL-8 was hampered by treatment with the phosphatidylinositol 3 (PI3) kinase inhibitor LY294002, suggesting that inhibition of Akt activation might inhibit IL-1beta, IL-6 and IL-8 production induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 137-145 C-X-C motif chemokine ligand 8 Homo sapiens 51-55 17314215-11 2007 TNF-alpha-induced production of IL-1beta, IL-6 and IL-8 was hampered by treatment with the phosphatidylinositol 3 (PI3) kinase inhibitor LY294002, suggesting that inhibition of Akt activation might inhibit IL-1beta, IL-6 and IL-8 production induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 137-145 C-X-C motif chemokine ligand 8 Homo sapiens 225-229 19103208-6 2009 Inhibitors of STAT1, mitogen activated protein kinase kinase (MEK) (PD98059), and phosphatidyl inositol 3 kinase (PI3K) (LY294002), blocked gp120-induced STAT1 activation and significantly diminished IL-8-, IL-6-, and gp120-induced monocyte adhesion and migration across in vitro BBB models. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 121-129 C-X-C motif chemokine ligand 8 Homo sapiens 200-204 18854173-4 2008 The PAR2-triggered IL-8 release was suppressed by inhibitors of MEK (U0126) or PI3-kinase (LY294002), and PAR2 stimulation indeed activated the downstream kinases, ERK and Akt. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 91-99 C-X-C motif chemokine ligand 8 Homo sapiens 19-23 16794257-3 2006 Pretreatment with quercetin and the PI 3-kinase inhibitor LY294002 each reduced TNF-alpha-induced IL-8 and monocyte chemoattractant protein (MCP)-1 (also called CCL2) expression in cultured human airway epithelial cells. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 58-66 C-X-C motif chemokine ligand 8 Homo sapiens 98-102 16798838-4 2006 The tyrosine kinase inhibitor Tyrphostin A9, phosphatidylinositol-3 kinase (PI3K) inhibitor LY294002 as well as proteasome inhibitors significantly blocked the CXCL8-induced chemotaxis of L1.2 cells and human neutrophils. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 92-100 C-X-C motif chemokine ligand 8 Homo sapiens 160-165 16798838-9 2006 The CXCL8-induced phosphorylation of Cbl was also reduced when cells were pre-treated with the PI3K inhibitor LY294002. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 110-118 C-X-C motif chemokine ligand 8 Homo sapiens 4-9 16253565-6 2006 The JNK inhibitor SP600125 and the PI3-kinase inhibitor LY294002 significantly blocked the poly(I:C)-induced release of RANTES and IL-8, whereas the p38 MAP kinase inhibitor SB203580 suppressed poly(I:C)-induced secretion of IL-8, but not RANTES. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 56-64 C-X-C motif chemokine ligand 8 Homo sapiens 131-135 16761312-7 2006 GIA activated the phosphatidylinositol 3-kinase (PI3 K)/Akt system and a specific inhibitor of PI3 K (LY294002) reduced sPLA(2)-induced release of TNF-alpha and CXCL8. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 102-110 C-X-C motif chemokine ligand 8 Homo sapiens 161-166 11971003-5 2002 Adhesion was blocked approximately 75% by inhibition of the phosphatidylinositol-3 kinase (PI3K) pathway with LY294002, supporting that activation of both MAPK and PI3K may play a role in IL-8-dependent inside-out signals that activate Mac-1. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 110-118 C-X-C motif chemokine ligand 8 Homo sapiens 188-192 12588890-9 2003 Albumin-induced ROS generation, NF-kappaB activation, and IL-8 secretion were endocytosis- and PKC-dependent as these downstream events were abrogated by the PI3K inhibitors LY294002 and wortmannin, and the PKC inhibitors GF109203X and staurosporin, respectively. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 174-182 C-X-C motif chemokine ligand 8 Homo sapiens 58-62 12379708-7 2002 IL-8 expression by TNF-alpha was inhibited when two survival signals, nuclear factor kappaB (NF-kappaB) and phosphatidylinositol 3-kinase (PI3K)/Akt, were inhibited by a mutant form of inhibitor of NF-kappaB (IkappaB); by dominant negative (kinase-dead) Akt; or by treatment with LY 294002, an inhibitor of PI3K. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 280-289 C-X-C motif chemokine ligand 8 Homo sapiens 0-4 16269654-10 2005 The inhibitory effect of adiponectin on TNF-alpha-induced IL-8 synthesis was abrogated in part by pretreatment with the PI3 kinase inhibitor LY294002 or by Akt siRNA transfection, suggesting that Akt activation might inhibit IL-8 synthesis induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 141-149 C-X-C motif chemokine ligand 8 Homo sapiens 58-62 16269654-10 2005 The inhibitory effect of adiponectin on TNF-alpha-induced IL-8 synthesis was abrogated in part by pretreatment with the PI3 kinase inhibitor LY294002 or by Akt siRNA transfection, suggesting that Akt activation might inhibit IL-8 synthesis induced by TNF-alpha. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 141-149 C-X-C motif chemokine ligand 8 Homo sapiens 225-229 11971003-6 2002 Activation of MAPK was inhibited in IL-8-stimulated cells in the presence of PI3K inhibitors LY294002 or wortmannin, supporting a model in which PI3K is upstream of MAPK. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 93-101 C-X-C motif chemokine ligand 8 Homo sapiens 36-40 11479233-9 2001 Inhibitors of MEK (U0126) and PI3K (LY294002) blocked p42/p44(erk) and Akt, respectively, and partially blocked HGF-induced production of IL-8 and VEGF, whereas the combination of U0126 and LY294002 completely inhibited expression of IL-8 and VEGF by UMSCC-11A. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 36-44 C-X-C motif chemokine ligand 8 Homo sapiens 138-142 11479233-9 2001 Inhibitors of MEK (U0126) and PI3K (LY294002) blocked p42/p44(erk) and Akt, respectively, and partially blocked HGF-induced production of IL-8 and VEGF, whereas the combination of U0126 and LY294002 completely inhibited expression of IL-8 and VEGF by UMSCC-11A. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 36-44 C-X-C motif chemokine ligand 8 Homo sapiens 234-238 10754327-13 2000 LY294002 blocked IL-8-dependent Akt phosphorylation. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 17-21 11028544-12 2000 To a lesser extent, incubation of TNFalpha with inhibitors to NF-kappaB (SN50) and PI3K (LY294002) also increased apoptosis and decreased IL-8 production (P < 0.05). 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 89-97 C-X-C motif chemokine ligand 8 Homo sapiens 138-142 10754327-14 2000 PD98059 and LY294002 significantly attenuated IL-8 delay of apoptosis. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 12-20 C-X-C motif chemokine ligand 8 Homo sapiens 46-50 9096344-3 1997 We demonstrate that phosphatidylinositol-3-kinase (PI3K) activity, as determined by inhibition using wortmannin and LY294002, is required for IL-8-induced cell migration of human neutrophils. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one 116-124 C-X-C motif chemokine ligand 8 Homo sapiens 142-146